خپرونې

FOI.ICB-2526/279: Lipoprotein(a) Policies and Testing

FOI.ICB-2526/261: eConsult Governance and Local DPIA Compliance at Courtside Surgery

FOI.ICB-2526/264: AIS Compliance Oversight for Courtside Surgery

FOI.ICB-21526/243: ADHD Expenditure

FOI.ICB-2526/257: Children’s Continuing Care and Direct Payments

FOI.ICB-2526/282: Use of GLP-1 and Other Diabetes and Weight Loss Medications in Prisons

FOI.ICB-2425/245: Infants with a Difference in Sexual Development

FOI.ICB-2526/239: Empiric Fluoroquinolone use in Enteric Epididymo-orchitis (EO)

FOI.ICB-2526/194: Rehabilitation Services

FOI.ICB-2526/218: Palliative Care for Children and Young People (CYP) with Life-limiting and Life-threatening Conditions

FOI.ICB-2526/255: Prescribing of Weight Loss Medicines

FOI.ICB-2526/246: Medicines Carbon Footprint Reporting 2024